6/7/23-Substance Use Disorder During Pregnancy

Presentation Resources

• American College of Obstetrics & Gynecology. (2017). Opioid Use and Opioid Use Disorder in Pregnancy.
  https://www.acog.org/clinical/clinical-guidance/committee-opinion/articles/2017/08/opioid-use-and-opioid-use-disorder-in-pregnancy

• Baidacchino 2014
  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4021271/

• Baldacchino 2014
  https://ncsacw.samhsa.gov/files/toolkitpackage/topic-prenatal/topic-prenatal-slides-508.pdf

• Bandstra 2010
  http://www.uky.edu/~sbarron/psy459/discussions/article1.pdf

• Behnke, M., Smith, V. C., & Committee on Substance Abuse. (2013). Prenatal substance abuse: Short- and long-term effects on the exposed fetus. Pediatrics, peds.2012-3931. doi:10.1542/peds.2012-3931
  https://pediatrics.aappublications.org/content/131/3/e1009

• Center for Behavioral Health Statistics and Quality. (2017). 2016 National Survey on Drug Use and Health: Detailed tables. Substance Abuse and Mental Health Services Administration, Rockville, MD. Retrieved from
  https://www.samhsa.gov/data/report/results-2016-national-survey-drug-use-and-health-detailed-tables

• Children and Family Futures

• Children and Family Futures. (2017). Collaborative values inventory. Retrieved from
  http://www.cffutures.org/files/cvi.pdf

• Ecker, J. et al. (2019). Substance use disorders in pregnancy: clinical, ethical, and research imperatives of the opioid epidemic: a report of a joint workshop of the Society for Maternal-Fetal Medicine, American College of Obstetricians and Gynecologists
  https://www.ajog.org/article/S0002-9378(19)30500-9/fulltext

• Friedman, S., Heneghan, A. & Rosenthal, M. (2009). Characteristics of women who do not seek prenatal care and implications for prevention. JOGNN, 38 (2), 174-181.
  ​​​​https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1552-6909.2009.01004.x

• Guttmacher Institute

• Jones, H. et al. (2010). Neonatal abstinence syndrome after methadone or buprenorphine exposure. New England Journal of Medicine, 363(24), 2320- 2331.
  MOTHER Study
  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3073631/

• Jones HE, Fischer G, Heil SH, et al. Maternal Opioid Treatment: Human Experimental Research (MOTHER) – Approach, Issues, and Lessons Learned.
  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4497510/

• McLellan AT, Lewis DC, O'Brien CP, Kleber HD. Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation. JAMA 284: 1689-1695

• Milliren, C. E., Gupta, M., Graham, D. A., Melvin, P., Jorina, M., & Ozonoff, A. (2017). Hospital variation in neonatal abstinence syndrome incidence, treatment modalities, resource use,and costs across pediatric hospitals in the United States, 2013 to 20
  https://hosppeds.aappublications.org/content/8/1/15.long

• Nygaard 2015
  https://www.researchgate.net/publication/324642176_Neuroanatomical_characteristics_of_youths_with_prenatal_opioid_and_poly-drug_exposure

• Nygaard 2015
  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4539602/

• Opioid Use Disorder In Pregnant Women
  https://www.michigan.gov/documents/mdhhs/NAS_Among_Michigan_Infants_2016_628379_7.pdf

• Patrick, S. W., Davis, M. M., Lehmann, C. U., & Cooper, W. O. (2015). Increasing incidence and geographic distribution of neonatal abstinence syndrome: United States 2009 to 2012. Journal of Perinatology, 35(8), 650–655. doi:10.1038/jp.2015.36
  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4520760/

• Ross, E., Graham, D., Money, K., & Stanwood, G. (2015). Developmental consequences of fetal exposure to drugs: what we know and what we still must learn. Neuropsychopharmacology, 40 (1), 61–87.
  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4262892/

• SAMHSA. (2018). Clinical Guidance for Treating Pregnant and Parenting Women with Opioid Use Disorders and Their Infants.
  https://store.samhsa.gov/sites/default/files/d7/priv/sma18-5054.pdf

• U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics. (2020). Births: Final data for 2019. National Vital Statistics Reports, 59(1). Hyattsville, MD: National Center for Health Sta
  https://www.cdc.gov/nchs/data/nvsr/nvsr67/nvsr67_01_tables.pdf

• Velez, M. L., & Jansson, L. M. (2015). Perinatal addictions: Intrauterine exposures. Textbook of Addiction Treatment: International Perspectives, 2333–2363. doi:10.1007/978-88-470- 5322-9_100
  https://www.researchgate.net/publication/300184533_Perinatal_Perinatal_Addictions_Intrauterine_Exposures

• Wong, J. 2018. Does maternal buprenorphine dose affect severity
  Abstract and Summary only at https://journals.lww.com/journaladdictionmedicine/Abstract/2018/12000/Does_Maternal_Buprenorphine_Dose_Affect_Severity.5.aspx

• Young, J. L., & Martin, P. R. (2012). Treatment of opioid dependence in the setting of pregnancy. Psychiatric Clinics of North America, 35, 441-460.
  Abstract and Key Points only at https://www.psych.theclinics.com/article/S0193-953X(12)00025-1/pdf

• Tsai, L. C., & Doan, T. J. (2016). Breastfeeding among mothers on opioid maintenance treatment: A literature review. Journal of Human Lactation, 32(3), 521–529. https://doi.org/10.1177/0890334416641909
  Abstract only

• Kaltenbach K, O’Grady KE, Heil SH, et al. Prenatal exposure to methadone or buprenorphine: Early childhood developmental outcomes. Drug AlcDepend. 2018;185:40-49

• SAMHSA. 2020. Tip 63. Medications for opioid use disorder

• Opioid Use Disorder During Pregnancy https://www.michigan.gov/documents/mdhhs/NAS_Among_Michigan_Infants_2016_628379_7.pdf
  Opioid Use Disorder During Pregnancy
  https://www.michigan.gov/documents/mdhhs/NAS_Among_Michigan_Infants_2016_628379_7.pdf

• Towers, C. V., Katz, E., Weitz, B., & Visconti, K. (2020). Use of naltrexone in treating opioid use disorder in pregnancy. American journal of obstetrics and gynecology, 222(1), 83-e
  Abstract Only

• Kelty, A Retrospective Cohort Study of Birth Outcomes in Neonates Exposed to Naltrexone in Utero: A Comparison with Methadone-, Buprenorphine- and Non-opioid-Exposed Neonates
  Abstract Only

Related Resources

Nitrous Oxide-a Viable and Modern Alternative for Inhalation Analgesia in Labor
https://revistadechimie.ro/pdf/38%20TUDORACHE%20I%205%2019.pdf

• Clinical guidelines for caring for women with COVID-19 during pregnancy, childbirth and the immediate postpartum period
  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7608012/
  please see pain mgmt section

• Manuel C. Vallejo, Mark I. Zakowski, "Pro-Con Debate: Nitrous Oxide for Labor Analgesia", BioMed Research International, vol. 2019, Article ID 4618798, 12 pages, .
  https://doi.org/10.1155/2019/4618798
  https://www.hindawi.com/journals/bmri/2019/4618798/